Inventor · disambiguated record
Sergio Abrignani
Also filed as: ABRIGNANI SERGIO
13 granted patents·18 pending applications·208 citations·filing 1995–2023
91Inventor score
Files withNOVARTIS VACCINES & DIAGNOSTIC9ABRIGNANI SERGIO3CHIRON SRL3ISTITUTO NAZ DI GENETICA MOLECOLARE INGM3CHECKMAB S R L2
Top patents by PatentIndex Score
31 records- 0195US7198923B1Method for the preparation of purified HCV RNA by exosome separationNOVARTIS VACCINES & DIAGNOSTIC·Filed 2000·Granted Apr 3, 2007·120 cites·21 claims
- 0293US6521423B1Intracellular production of Hepatitis C E2 polypeptidesCHIRON CORP·Filed 2000·Granted Feb 18, 2003·32 cites·13 claims
- 0391US7807438B2Preparation of purified exosomes comprising HCV RNANOVARTIS AG·Filed 2007·Granted Oct 5, 2010·18 cites·14 claims
- 0482US7429385B2Intracellular production of hepatitis C E1 and E2 truncated polypeptidesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Sep 30, 2008·6 cites·3 claims
- 0577US7320875B2Hepatitis C virus E2 binding proteinCHIRON SRL·Filed 2006·Granted Jan 22, 2008·2 cites·4 claims
- 0674US12247982B2Markers selectively deregulated in tumor-infiltrating regulatory T cellsCHECKMAB S R L·Filed 2023·Granted Mar 11, 2025·0 cites·1 claims
- 0774US2010143293A1T cell activationNOVARTIS AG·Filed 2009·Application pending·0 cites
- 0873US7329408B2Eliciting HCV-specific antibodiesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2000·Granted Feb 12, 2008·6 cites·43 claims
- 0969US6074635AT cell activationCHIRON SPA·Filed 1995·Granted Jun 13, 2000·20 cites·6 claims
- 1068US7754228B2Cytotoxic T-cell epitopes from ChlamydiaNOVARTIS VACCINES & DIAGNOSTIC·Filed 2003·Granted Jul 13, 2010·3 cites·4 claims
- 1165US2009025098A1Hepatitis C receptor protein CD81NOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Application pending·0 cites
- 1264US7026130B2Binding proteinCHIRON CORP·Filed 2004·Granted Apr 11, 2006·1 cites·5 claims
- 1361US2007087407A1Hepatitis C receptor protein CD81NOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Application pending·0 cites
- 1459US7097987B2Hepatitis C receptor protein CD81NOVARTIS VACCINES & DIAGNOSTIC·Filed 2004·Granted Aug 29, 2006·0 cites·2 claims
- 1559US2008095800A1Eliciting HCV-specific antibodiesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2007·Application pending·0 cites
- 1659US2010203501A1Assay to detect HCV receptor bindingABRIGNANI SERGIO·Filed 2009·Application pending·0 cites
- 1757US2008176219A1Assay to detect HCV receptor bindingNOVARTIS VACCINES & DIAGNOSTIC·Filed 2008·Application pending·0 cites
- 1855US2012066779A1Hepatitis c receptor protein cd81ABRIGNANI SERGIO·Filed 2011·Application pending·0 cites
- 1954US2007298410A1Assay to detect HCV receptor bindingABRIGNANI SERGIO·Filed 2007·Application pending·0 cites
- 2053US2005281793A1T cell activationCHIRON SPA·Filed 2005·Application pending·0 cites
- 2151US6777538B2Binding proteinCHIRON SRL·Filed 2001·Granted Aug 17, 2004·0 cites·10 claims
- 2250US2011038875A1Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3ISTITUTO NAZ DI GENETICA MOLECOLARE INGM·Filed 2009·Application pending·0 cites
- 2350US2010183562A1Sub -population of hematopoietic stem cells that express the crisp-1 proteinISTITUTO NAZ DI GENETICA MOLEC·Filed 2008·Application pending·0 cites
- 2450US2010166777A1Hematopoietic cells that express mosc-1ISTITUTO NAZ DI GENETICA MOLEC·Filed 2008·Application pending·0 cites
- 2550US2011002938A1Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3ISTITUTO NAZ DI GENETICA MOLECOLARE INGM·Filed 2009·Application pending·0 cites
- 2650US2015065375A1Acquired immunity biomarkers and uses thereofISTITUTO NAZ DI GENETICA MOLECOLARE INGM·Filed 2013·Application pending·0 cites
- 2745US2011159039A1Eliciting hcv-specific antibodiesHOUGHTON MICHAEL·Filed 2010·Application pending·0 cites
- 2843US2019391152A1Markers selectively deregulated in tumor-infiltrating regulatory t cellsCHECKMAB S R L·Filed 2017·Application pending·0 cites
- 2940US2014106987A1Biomarkers for autoimmune liver diseases and uses thereofISTITUTO NAZ GENETICA MOLECOLARE INGM·Filed 2012·Application pending·0 cites
- 3033US2012238617A1Microrna expression signature in peripheral blood of patients affected by hepatocarcinoma or hepatic cirrhosis and uses thereofPAGANI MASSIMILIANO·Filed 2010·Application pending·0 cites
- 3131US6737233B1Method for preparing HCV E2 binding proteinCHIRON SRL·Filed 1996·Granted May 18, 2004·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Sergio Abrignani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →